European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Download Description Authors
Recently, there have been significant advances in the field of osteoporosis management. A new, simple, WHO-validated method of assessing fracture risk has been developed, as have new treatments that have been shown to significantly reduce the risk of fractures at vulnerable sites. Against this background, the European Society for Clinical and Economic Evaluation of Osteoporosis and Osteoarthritis (ESCEO), in collaboration with the IOF, has developed new guidelines . J. A. Kanis, N. Burlet, C. Cooper , P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli. On behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Osteoporos Int (2008) 19:399-428

ESCEO Pocket Guidelines


Document Description Download
European Society for Clinical and Economic Evaluation of Osteoporosis and Osteoarthritis (ESCEO), in collaboration with the IOF, has developed new guidelines (see below) and has published a practical summary in "pocket" format in five languages, available here. Please note that the management algorithms are based on a health economic analysis applied to the epidemiology of fracture in the UK and may require adaptation for other European countries. English
German
Spanish
French
Italian

Other publications


Download Title Authors
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club J.-J Body, P. Bergmann, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis R. Rizzoli, N. Burlet, D. Cahall, P. D. Delmas, E. F. Eriksen, D. Felsenberg, J. Grbic, M. Jontell, R. Landesberg, A. Laslop, M. Wollenhaupt, S. Papapoulos, O. Sezer, M. Sprafka, J.-Y. Reginster
The role of calcium and vitamin D in the management of osteoporosis R. Rizzoli, S. Boonen, M.-L. Brandi, N. Burlet, P. Delmas, J.-Y. Reginster
European regulatory perspectives for innovative therapies S. Ormarsdottir, J.-Y. Reginster, E. Abadie
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system O. Bruyère, N. Burlet, P. D. Delmas, R. Rizzoli, C. Cooper and J.-Y. Reginster
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science J. Compston, D.M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P.D. Delmas, W. Dere, J.-P. Devogelaer, L.A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women O. Bruyere, A. R. Varela, S. Adami, J. Detilleux, V. Rabenda, M. Hiligsmann, J.-Y. Reginster
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity P. Musette, M. L. Brandi, P. Cacoub, J. M. Kaufman, R. Rizzoli, J.-Y. Reginster
Management of osteoporosis in the elderly R. Rizzoli, O. Bruyere, J. B. Cannata-Andia, J.-P. Devogelaer, G. Lyritis, J. D. Ringe, B. Vellas, J.-Y. Reginster
Post-fracture management of patients with hip fracture: a perspective O. Bruyere, M.-L. Brandi, N. Burlet, N. Harvey, G. Lyritis, H. Minne, S. Boonen, J.-Y. Reginster, R. Rizzoli and K. Akesson
European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women V. Rabenda, R. Mertens, V. Fabri, J. Vanoverloop, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster
Adherence to treatment of osteoporosis: a need for study F. Lekkerkerker, J. A. Kanis, N. Alsayed, G. Bouvenot, N. Burlet, D. Cahall, A. Chines, P. Delmas, R.-L. Dreiser, D. Ethgen, N. Hughes, J.-M. Kaufman, S. Korte, G. Kreutz, A. Laslop, B. Mitlak, V. Rabenda, R. Rizzoli, A. Santora, R. Schimmer, Y. Tsouderos, P. Viethel, J.-Y. Reginster
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis J. Goldhahn, W. H. Scheele, B. Mitlak, E. Abadie, P. Aspenberg, P. Augat, M.-L. Brandi, N. Burlet, A. Chines, P. D. Delmas, I. Dupin-Roger, D. Ethgen, B. Hanson, F. Hartl, J. Kanis, R. Kewalramani, A. Laslop, D. Marsh, S. Ormarsdottir, R. Rizzoli, A. Santora, G. Schmidmaier, M. Wagener, J.-Y. Reginster
Critical Issues in Translational and Clinical Research for the Study of New Technologies to Enhance Bone Repair J. Goldhahn, B. Mitlak P. Aspenberg, J. Kanis, R. Rizzoli, J.-Y. Reginster
Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture V. Rabenda, J. Vanoverloop, V. Fabri, R. Mertens, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence V. Rabenda, M. Hiligsmann, J.-Y. Reginster
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures V. Rabenda, J.-Y. Reginster
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men J.-Y. Reginster, E. Abadie, P. Delmas, R. Rizzoli, W. Dere, P. der Auwera, B. Avouac, M.-L. Brandi, A. Daifotis, A. Diez-Perez, G. Calvo, O. Johnell, J.-M. Kaufman, G. Kreutz, A. Laslop, F. Lekkerkerker, B. Mitlak, P. Nilsson, J. Orloff, M. Smillie, A. Taylor, Y. Tsouderos, D. Ethgen, B. Flamion
Therapeutic Adherence with Bisphosphonates in the Treatment of Osteoporosis V. Rabenda, J.-Y. Reginster
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women O. Bruyere, A. R. Varela, S. Adami, J. Detilleux,V. Rabenda, M. Hiligsmann, J.-Y. Reginster

Other files


Download Title Kind
IOF WCO - ECCEO10 / ECCEO11-IOF / IOF-ECCEO12 Visual Microsoft Powerpoint file.